Sneak peek: End of life care at home for exotics, and other veterinary news

Happy Monday, dvm360 readers! We hope everyone had a great weekend and are looking forward to another week. Did you know that for the month of March, dvm360 will be recognizing Parasite Awareness Month and spotlighting Diabetes Nutrition? Be on the lookout throughout the month for expert interviews, articles, and more on these 2 topics!

In addition to our awareness month spotlights, here is what else you will be able to find this week on dvm360.com:

• In an article contributed by Tyler Carmack, DVM, CVA, CVFT, CHPV, CTPEP, CVPP, director of hospice and palliative care at Caring Pathways, she shared clinical considerations for exotic patients who will be euthanized at home, how to communicate and support the client, and how it differs from canine and feline patient.

• On this week’s episode of The Vet Blast Podcast presented by dvm360, Renee Schmid, DVM, DABT, DABVT, joins the show to talk about toxicology misconceptions with our host Adam Christman, DVM, MBA.
• Northern Thailand is reporting that 72 tiger deaths in parks popular with tourists located in Mae Taeng and Mae Rim districts of Chiang Mai province were caused by canine distemper and there were traces of bacterial infection found, but no avian influenza type A virus.
• A national survey conducted by the American Animal Hospital Association, in collaboration with Gallant, found that there is strong interest among veterinary professionals in the US to expand options for inflammatory disease in patients, including 95% of respondents stating they believe stem cell therapy will be a standard treatment option within the next decade in the spectrum of care.
• Researchers at the University of Liverpool’s Veterinary Data Science Group and the University of Las Palmas de Gran Canaria have created the largest open-source database of canine and feline tumors in the world. The database contains over 1 million records and can be used as a resource to gain a better understanding of the factors that influence the risks of patients getting cancer.